Back
Intellia Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
NTLA
Intellia Therapeutics
Last Price:
$11.82
Seasonality Move:
-9.64%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight buying pressure.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.57 | Buy |
| 20-day SMA: | 10.46 | Buy |
| 50-day SMA: | 9.17 | Buy |
| 200-day SMA: | 11.61 | Buy |
| 8-day EMA: | 9.76 | Buy |
| 20-day EMA: | 5.93 | Buy |
| 50-day EMA: | 2.87 | Buy |
| 200-day EMA: | 0.8 | Buy |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.22 | Buy |
| Relative Strength Index (14 RSI): | 65.91 | Buy |
| Chaikin Money Flow: | 459558 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.84 - 11.3) | Buy |
| Bollinger Bands (100): | (7.49 - 10.37) | Buy |
Intellia Therapeutics Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 11.96 while NTLA 8-day simple moving average is 11.57, which is a Buy signal.
-
The stock price of NTLA is 11.96 while Intellia Therapeutics 20-day SMA is 10.46, which makes it a Buy.
-
Intellia Therapeutics 50-day simple moving average is 9.17 while NTLA share price is 11.96, making it a Buy technically.
-
NTLA stock price is 11.96 and Intellia Therapeutics 200-day simple moving average is 11.61, creating a Buy signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
31
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a SellThe current Intellia Therapeutics [NTLA] share price is $11.96. The Score for NTLA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
1.2B
Price in USD:
11.96
Share Volume:
3.7M
Intellia Therapeutics 52-Week Range
52-Week High:
28.18
52-Week Low:
5.90
Sell
31
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?The Intellia Therapeutics stock price is 11.96 USD today.
-
Will NTLA stock go up or go down?Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Intellia Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
-
Intellia Therapeutics share price is 11.96 while NTLA 8-day exponential moving average is 9.76, which is a Buy signal.
-
The stock price of NTLA is 11.96 while Intellia Therapeutics 20-day EMA is 5.93, which makes it a Buy.
-
Intellia Therapeutics 50-day exponential moving average is 2.87 while NTLA share price is 11.96, making it a Buy technically.
-
NTLA stock price is 11.96 and Intellia Therapeutics 200-day simple moving average is 0.80, creating a Buy signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.10 per share, an increase this year of $1.13 per share, and an increase next year of $0.30 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
-
NTLA Moving Average Covergence Divergence (MACD) indicator is 3.22, suggesting Intellia Therapeutics is a Buy
-
Intellia Therapeutics Relative Strength Index (RSI) is 65.91, which suggest Intellia Therapeutics is overbought
-
The Bollinger Bands (25) for Intellia Therapeutics is (8.84 - 11.3), which suggest Intellia Therapeutics is a Buy
-
The Bollinger Bands (100) for Intellia Therapeutics is (7.49 - 10.37), which suggest Intellia Therapeutics is a Buy
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.